4.4 Article

CD20+cells blockage by rituximab delays wound healing in oral traumatic ulcers in rats

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Inhibition of CD39 unleashes macrophage antibody-dependent cellular phagocytosis against B-cell lymphoma

Mika Casey et al.

Summary: In DLBCL, CD39 is highly expressed while CD73 is undetectable in tumor cells. Inhibiting CD39 enhances macrophage engulfment of antibody-coated lymphoma cells, thereby increasing the anti-lymphoma effects of therapeutic antibodies.

LEUKEMIA (2022)

Article Immunology

Tumor necrosis factor alpha (TNF-α) blockage reduces acute inflammation and delayed wound healing in oral ulcer of rats

Milena Oliveira Freitas et al.

Summary: The study aimed to evaluate the role of TNF-alpha in the healing process of oral traumatic ulcers (OTU) in rats. The results showed that high doses of INF reduced the OTU area, body mass loss, vascular permeability, and delayed histologic scores, as well as reduced cellular components such as polymorphonuclear and mononuclear cells. INF treatment also reduced TNF-alpha immunostaining and delayed the expression of MPC-1, FGF, and alpha-SMA, with little influence on IL-8 immunostaining. The blockage of TNF-alpha by INF reduced acute inflammation in OTU but delayed cell migration and wound healing.

INFLAMMOPHARMACOLOGY (2022)

Review Pharmacology & Pharmacy

Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint

TingTing Tang et al.

Summary: The CD40 receptor and its ligand CD40L play a critical role in immune activation, with various therapeutic agents targeting this interaction showing promising clinical efficacy in treating malignancies and autoimmune diseases. The signaling pathways activated by CD40/CD40L interaction lead to immune cell activation and modulation, making it an attractive target for immunotherapy. Ongoing and completed clinical trials have demonstrated the potential of CD40/CD40L-targeted therapy in activating immune responses and treating diseases.

PHARMACOLOGY & THERAPEUTICS (2021)

Review Oncology

New insights into M1/M2 macrophages: key modulators in cancer progression

Jiuyang Liu et al.

Summary: This article examines the critical roles of M1 and M2 macrophages in tumor progression, with M1 possessing anti-tumor properties and M2 promoting tumor growth and metastasis.

CANCER CELL INTERNATIONAL (2021)

Review Rheumatology

Lyme arthritis: linking infection, inflammation and autoimmunity

Robert B. Lochhead et al.

Summary: Lyme arthritis, caused by Borrelia burgdorferi, can be effectively treated with antibiotics in most patients, but in some cases, post-infectious arthritis may persist. The dysregulated immune response during and after infection plays a key role in the pathogenesis of this chronic inflammatory arthritis.

NATURE REVIEWS RHEUMATOLOGY (2021)

Review Immunology

TGF-β-secreting regulatory B cells: unsung players in immune regulation

Guoli Huai et al.

Summary: Regulatory B cells play a crucial role in various diseases, with B cells producing TGF-beta also regulating T-cell immunity and promoting the emergence of regulatory T cells. While studies on these cells have been conducted in allergy, cancer, and autoimmune diseases, their role in transplantation is still under limited scrutiny.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)

Review Rheumatology

Effects of rituximab therapy on B cell differentiation and depletion

L. Bergantini et al.

CLINICAL RHEUMATOLOGY (2020)

Article Dentistry, Oral Surgery & Medicine

Influence of infliximab therapy on bone healing post-dental extraction in rats

Antonio Ernando Carlos Ferreira-Junior et al.

ARCHIVES OF ORAL BIOLOGY (2020)

Review Pathology

Ulcerated Lesions of the Oral Mucosa: Clinical and Histologic Review

Sarah G. Fitzpatrick et al.

HEAD & NECK PATHOLOGY (2019)

Review Medicine, General & Internal

Wound healing

Peng-Hui Wang et al.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2018)

Review Medicine, Research & Experimental

Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

Gilles Salles et al.

ADVANCES IN THERAPY (2017)

Article Multidisciplinary Sciences

B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy

Wilhelmina M. C. Timmermans et al.

PLOS ONE (2016)

Article Chemistry, Multidisciplinary

Interspecies Pharmacokinetic Modeling of Subcutaneous Absorption of Rituximab in Mice and Rats

Leonid Kagan et al.

PHARMACEUTICAL RESEARCH (2014)

Review Immunology

Regulatory B cells in autoimmune diseases

Min Yang et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2013)

Article Dentistry, Oral Surgery & Medicine

Association of cell adhesion molecule gene polymorphisms with recurrent aphthous stomatitis

Asem Alkhateeb et al.

JOURNAL OF ORAL PATHOLOGY & MEDICINE (2013)

Article Dermatology

Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: A retrospective study of 47 patients

Yael A. Leshem et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)

Article Cell Biology

Detrimental dermal wound healing: What can we learn from the oral mucosa?

Judith E. Glim et al.

WOUND REPAIR AND REGENERATION (2013)

Article Immunology

Role of Interleukin 10 Transcriptional Regulation in Inflammation and Autoimmune Disease

Shankar Subramanian Iyer et al.

CRITICAL REVIEWS IN IMMUNOLOGY (2012)